上海勁馬實驗設(shè)備有限公司作者
勁馬產(chǎn)品文獻:小鼠白介素1β (IL-1β)、(TNF-α)ELISA試劑盒引用文獻
資料類型 | pdf文件 | 資料大小 | 1879765 |
下載次數(shù) | 0 | 資料圖片 | 【點擊查看】 |
上 傳 人 | 上海勁馬實驗設(shè)備有限公司 | 需要積分 | 0 |
關(guān) 鍵 詞 | 勁馬產(chǎn)品文獻:小鼠白介素1β (IL-1β)、(TNF-α)ELISA試劑盒引用文獻 |
- 【資料簡介】
【文獻標(biāo)題】Crocetin Downregulates the Proinflammatory Cytokines in Methylcholanthrene-Induced Rodent Tumor Model and Inhibits COX-2 Expression in Cervical Cancer Cells
【作者】Bing Chen, Zhao-Hui Hou, Zhe Dong,et.al
【作者單位】Air Force General Hospital(空軍總醫(yī)院)
【文獻中引用產(chǎn)品】
小鼠白介素1β (IL-1β)ELISA試劑盒
小鼠腫瘤壞死因子α(TNF-α)ELISA試劑盒
【關(guān)鍵詞】
【DOI】doi.org/10.1155/2015/829513
【影響因子(IF)】3.24
【出版期刊】《Biomed Research International》
【產(chǎn)品原文引用】
Measurement of IL-1β and TNF-α Level. The concentration of IL-1β and TNF-α was determined using a commercial ELISA kit (Shanghai Jinma Biological Technology, Inc.,China) following the manufacturer’s instruction.
Assessment of iNOS Protein Histochemistry. The tumors were dissected free from soft tissues at the end of the study and collected on chrome gel subbed slides. Tissue sections were fixed in 50% acetone in phosphate-buffered saline for 3 minutes at room temperature and endogenous peroxidase activity was blocked by 1.5% H2O2 in methanol for 15 minutes. The iNOS protein was determined using a commercial ELISA kit (Shanghai Jinma Biological Technology, Inc.,China) following the manufacturer’s instruction.
Crocetin Inhibited COX-2 Production in HeLa Cells. Analysis of COX-2 production was performed using an ELISA kit according to manufacturer’s instructions (Shanghai Jinma Biological Technology, Inc., China). HeLa cells were treated with various concentrations of crocetin (1, 10, 50, and100 mol/L) for 24 h. Cell culture supernatants were collected to measure the concentration of COX-2. Production of COX-2 was normalized to protein concentrations.
完整版PDF文獻請咨詢在線客服或者聯(lián)系我司業(yè)務(wù)員!
更多公司福利請關(guān)注“上海勁馬”微信公眾號!
上一篇:了解臺式應(yīng)力儀的功能
- 凡本網(wǎng)注明"來源:環(huán)保在線"的所有作品,版權(quán)均屬于環(huán)保在線,轉(zhuǎn)載請必須注明環(huán)保在線,http://m.mividagoldenbeach.com。違反者本網(wǎng)將追究相關(guān)法律責(zé)任。
- 企業(yè)發(fā)布的公司新聞、技術(shù)文章、資料下載等內(nèi)容,如涉及侵權(quán)、違規(guī)遭投訴的,一律由發(fā)布企業(yè)自行承擔(dān)責(zé)任,本網(wǎng)有權(quán)刪除內(nèi)容并追溯責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其它來源的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點或證實其內(nèi)容的真實性,不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉(zhuǎn)載時,必須保留本網(wǎng)注明的作品來源,并自負版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問題,請在作品發(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。